Study Results
The study team has not published outcome measurements, participant flow, or safety data for this trial yet. Check back later for updates.
Basic Information
Get a concise snapshot of the trial, including recruitment status, study phase, enrollment targets, and key timeline milestones.
ENROLLING_BY_INVITATION
15000 participants
OBSERVATIONAL
2014-01-31
2030-12-31
Brief Summary
Review the sponsor-provided synopsis that highlights what the study is about and why it is being conducted.
Related Clinical Trials
Explore similar clinical trials based on study characteristics and research focus.
Infliximab to Treat Children With Juvenile Rheumatoid Arthritis
NCT00029042
Study to Evaluate the Safety and Tolerability of Two Doses of Rilonacept in Pediatric Subjects With Active Systemic Juvenile Idiopathic Arthritis (SJIA)
NCT01803321
A Study of Canakinumab in Patients With Systemic Juvenile Idiopathic Arthritis or Hereditary Periodic Fevers Who Participated in the CACZ885G2301E1, CACZ885G2306 or CACZ885N2301 Studies
NCT02334748
Strategies Towards Personalised Treatment in Juvenile Idiopathic Arthritis (JIA).
NCT04614311
Ilaris (Canakinumab) in the Schnitzler Syndrome
NCT01245127
Detailed Description
Dive into the extended narrative that explains the scientific background, objectives, and procedures in greater depth.
Different data are requested in the JIR-cohort: diagnosis, treatment, adverse events and outcome.
Conditions
See the medical conditions and disease areas that this research is targeting or investigating.
Study Design
Understand how the trial is structured, including allocation methods, masking strategies, primary purpose, and other design elements.
COHORT
PROSPECTIVE
Study Groups
Review each arm or cohort in the study, along with the interventions and objectives associated with them.
Juvenile Inflammatory Rheumatism
Juvenile Inflammatory Rheumatism patients
No interventions assigned to this group
Eligibility Criteria
Check the participation requirements, including inclusion and exclusion rules, age limits, and whether healthy volunteers are accepted.
Inclusion Criteria
* Age at onset up to 18 years old
* Consent according national codes of ethics and current laws
Exclusion Criteria
ALL
No
Sponsors
Meet the organizations funding or collaborating on the study and learn about their roles.
Hospices Civils de Lyon
OTHER
Versailles Hospital
OTHER
Tenon Hospital, Paris
OTHER
Bicetre Hospital
OTHER
University of Lausanne Hospitals
OTHER
University Hospital Muenster
OTHER
Fondation Rhumatismes-Enfants-Suisse
UNKNOWN
Michaël Hofer
OTHER
Responsible Party
Identify the individual or organization who holds primary responsibility for the study information submitted to regulators.
Michaël Hofer
Head of Pediatric Rheumatology unit
Principal Investigators
Learn about the lead researchers overseeing the trial and their institutional affiliations.
Michael Hofer
Role: STUDY_DIRECTOR
University of Lausanne Hospitals
Véronique Hentgen
Role: STUDY_DIRECTOR
Versailles Hospital
Locations
Explore where the study is taking place and check the recruitment status at each participating site.
Hôpital Reine Fabiola
Brussels, , Belgium
CHU Charleroi
Charleroi, , Belgium
UZ Leuven
Leuven, , Belgium
CHC Liège
Liège, , Belgium
CHR Citadelle
Liège, , Belgium
CHU Belfort
Belfort, , France
CHRU Besançon
Besançon, , France
Hôpital Pellegrin enfants
Bordeaux, , France
CHRU Brest
Brest, , France
Hôpital Femme Mère Enfant
Bron, , France
CHU Clermont-Ferrand
Clermont-Ferrand, , France
CHU de Grenoble
Grenoble, , France
Hôpital Bicêtre
Le Kremlin-Bicêtre, , France
CHRU Lille
Lille, , France
Hôpital Nord Marseille
Marseille, , France
CHU Arnaud de Villeneuve
Montpellier, , France
Centre hospitalier de Mulhouse
Mulhouse, , France
CHU Nantes
Nantes, , France
Nice CHU - Lenval
Nice, , France
CHU Nimes
Nîmes, , France
Hôpital necker Enfants Malade
Paris, , France
Hôpital Robert Debré
Paris, , France
Hôpital Tenon
Paris, , France
CHU Reims
Reims, , France
CHU Rennes
Rennes, , France
CHU St-Etienne
Saint-Etienne, , France
Hôpital de Hautepierre
Strasbourg, , France
Hôpital des enfants
Toulouse, , France
CHU Tours
Tours, , France
Hôpital André Mignot
Versailles, , France
University Hospital Muenster
Münster, , Germany
Hôpital Ibnou Rochd
Casablanca, , Morocco
CHUV
Lausanne, Canton of Vaud, Switzerland
Kantonsspital Aarau
Aarau, , Switzerland
Kinderspital Basel
Basel, , Switzerland
Universitäts-Augenklinik Basel
Basel, , Switzerland
Ospedale Regionale di Bellinzona e valli
Bellinzona, , Switzerland
Kantonspital Graubunden
Chur, , Switzerland
Hôpital Ophtalmique
Lausanne, , Switzerland
Kinderspital Luzern
Lucerne, , Switzerland
Ospedale Regionale di Lugano
Lugano, , Switzerland
Ostschweizer Kinderspital St-Gallen
Sankt Gallen, , Switzerland
Klinik für Rheumatologie und internistische Rehabilitation
Valens, , Switzerland
Kantonspital Winterthur
Winterthur, , Switzerland
Kinderspital Zürich
Zurich, , Switzerland
Countries
Review the countries where the study has at least one active or historical site.
References
Explore related publications, articles, or registry entries linked to this study.
Pouletty M, Borocco C, Ouldali N, Caseris M, Basmaci R, Lachaume N, Bensaid P, Pichard S, Kouider H, Morelle G, Craiu I, Pondarre C, Deho A, Maroni A, Oualha M, Amoura Z, Haroche J, Chommeloux J, Bajolle F, Beyler C, Bonacorsi S, Carcelain G, Kone-Paut I, Bader-Meunier B, Faye A, Meinzer U, Galeotti C, Melki I. Paediatric multisystem inflammatory syndrome temporally associated with SARS-CoV-2 mimicking Kawasaki disease (Kawa-COVID-19): a multicentre cohort. Ann Rheum Dis. 2020 Aug;79(8):999-1006. doi: 10.1136/annrheumdis-2020-217960. Epub 2020 Jun 11.
Related Links
Access external resources that provide additional context or updates about the study.
Official jir-cohorte project webpage
Other Identifiers
Review additional registry numbers or institutional identifiers associated with this trial.
JIR-001
Identifier Type: -
Identifier Source: org_study_id
More Related Trials
Additional clinical trials that may be relevant based on similarity analysis.